- Latest week
- 10 Jul 2026
- Close
- 2.500000
- Fair value
- 1.993000
- Next-week expectancy
- Undecided 47.37%
VLS Chart Pack
Vita Life Sciences Limited
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, VLS fell 3.10%, moving from 2.58 to 2.50. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 9 of the last 12 weeks. Relative Strength is 3.91 and has softened across the 12-week window. Market Dynamics is -0.88 on the latest week. Next-week expectancy is undecided at 47.37% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 2.50
- 12-Week Change
- -3.10%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 47.37%
- Signal Weeks
- 9 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 3.91
- Market Dynamics
- -0.88
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 2.50
- 12-Week Change
- -3.10%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 47.37%
- Signal Weeks
- 9 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 3.91
- Market Dynamics
- -0.88
Over the latest 12 completed weeks ending 2026-07-10, VLS fell 3.10%, moving from 2.58 to 2.50. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 9 of the last 12 weeks. Relative Strength is 3.91 and has softened across the 12-week window. Market Dynamics is -0.88 on the latest week. Next-week expectancy is undecided at 47.37% based on similar historical setup states.
Industry Peers
Australia equities in Drug Manufacturers - Specialty & Generic
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| RGT Argent BioPharma Limited | ASX | 10 Jul 2026 | 0.04 | 0.11 | 0.04 | 0.07 | 105.71% |
| IVX Invion Limited | ASX | 10 Jul 2026 | 0.03 | 0.04 | 0.03 | 0.04 | 15.62% |
| LGP Little Green Pharma Ltd | ASX | 10 Jul 2026 | 0.07 | 0.07 | 0.07 | 0.07 | 4.48% |
| IDT IDT Australia Limited | ASX | 10 Jul 2026 | 0.03 | 0.03 | 0.03 | 0.03 | 3.23% |
| AFP AFT Pharmaceuticals Limited | ASX | 10 Jul 2026 | 3.04 | 3.30 | 3.04 | 3.13 | 2.96% |
| BP8 BPH Global Ltd | ASX | 10 Jul 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
| ECS ECS Botanics Holdings Ltd | ASX | 10 Jul 2026 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00% |
| EPN Epsilon Healthcare Limited | ASX | 10 Jul 2026 | 0.02 | 0.02 | 0.02 | 0.02 | 0.00% |
| EXL Elixinol Wellness Limited | ASX | 10 Jul 2026 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00% |
| PER PERCHERON FPO [PER] | ASX | 10 Jul 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
| VIT Vitura Health Limited | ASX | 10 Jul 2026 | 0.03 | 0.03 | 0.03 | 0.03 | 0.00% |
| MVP Medical Developments International Limited | ASX | 10 Jul 2026 | 0.42 | 0.44 | 0.41 | 0.41 | -2.41% |
| PKP PEAK FPO [PKP] | ASX | 10 Jul 2026 | 0.02 | 0.02 | 0.02 | 0.02 | -5.56% |
| SNT Syntara Limited | ASX | 10 Jul 2026 | 0.03 | 0.03 | 0.02 | 0.02 | -8.00% |
| CAN Cann Group Limited | ASX | 10 Jul 2026 | 0.01 | 0.01 | 0.00 | 0.00 | -10.00% |